practice portal / healthcare entities / non-regulatory solutions / communication tools / mainstream media / healthcare providers / /
MedicalCondition
MS / /
Organization
office of External Affairs Committee Questions and Discussion Guest / office of Planning Risk Communication / Risk Communications Advisory Committee / office of Health Affairs and Constituent Affairs / Food and Drug Administration / COMMUNICATION ADVISORY COMMITTEE / office of External Affairs / Food and Drug Administration Office / National Research Center for Women and Families / Center for Drug / Evaluation and Research / office of Health and Constituent Affairs Committee Questions / office of Health and Constituent Affairs / /
Person
Gavin Huntley-Fenner / Ji Sun Lee / Luis G. Bravo / Nananda Col / Dale Slavin / Norman Marks / Heidi C. Marchand / D. Steven Immergut / N. Harold J. DeMonaco / Silver Spring / D. Luis G. Bravo / Luis G. Bravo Designated / Jeremy N. Kees / Harold J. DeMonaco / P.H. Dale Slavin / William Hallman / Steven Immergut / RCAC FDA / M.D. Moshe Engelberg / D. Heidi C. Marchand / Carolyn J. Strickland / Daniel G. Morrow / Anna Fine / Stacy Bridges / Noel T. Brewer / /
Position
Federal Officer / Acting Director / CDER Committee / Director / Risk Communication Staff / Office / Acting Director / Speaker / Commissioner / Clinical Advisor / Acting Chair / Assistant Commissioner / Assistant Commissioner / Officer / speaker for the Open Public Hearing session / Assistant / Medical Advisor / Federal Official / Clinical Advisor / Health News Review / Medical Officer / Officer / R.N. / Director / CDER Committee / Officer of Health and Constituent Affairs / /
Food and Drug Administration Office of the Commissioner / Office of Planning Risk Communication Staff SUMMARY MINUTES RISK COMMUNICATION ADVISORY COMMITTEE (RCAC)